LENZ Therapeutics, Inc.
General ticker "LENZ" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $844.3M (TTM average)
LENZ Therapeutics, Inc. follows the US Stock Market performance with the rate: 7.6%.
Estimated limits based on current volatility of 3.6%: low 11.37$, high 12.22$
Factors to consider:
- Earnings expected soon, date: 2026-03-18 bmo
- Total employees count: 69 as of 2021
- Current price 17.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [19.92$, 44.07$]
- 2025-12-31 to 2026-12-31 estimated range: [14.18$, 33.26$]
Short-term LENZ quotes
Long-term LENZ plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $58.61MM |
| Operating Income | $-58.61MM |
| Non-Operating Income | $8.84MM |
| R&D Expense | $29.80MM |
| Income(Loss) | $-49.77MM |
| Taxes | $0.00MM |
| Profit(Loss)* | $-49.77MM |
| Stockholders Equity | $204.08MM |
| Assets | $215.30MM |
| Operating Cash Flow | $-59.39MM |
| Capital expenditure | $0.47MM |
| Investing Cash Flow | $-154.48MM |
| Financing Cash Flow | $199.00MM |
| Earnings Per Share** | $-2.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.